Correction: PID1 alters the antilipolytic action of insulin and increases lipolysis via inhibition of AKT/PKA pathway activation
Correction: PID1 alters the antilipolytic action of insulin and increases lipolysis via inhibition of AKT/PKA pathway activation
复制标题
修正:PID1 改变胰岛素的抗脂解作用,并通过抑制 AKT/PKA 通路激活来增加脂解作用
DOI:
10.1371/journal.pone.0214606
复制
发表时间:
2019-06
期刊:
影响因子:
3.7
通讯作者:
Yanfeng Xiao
中科院分区:
文献类型:
--
作者:
Chunyan Yin;Wei hua Liu;Yuesheng Liu;Li Wang;Yanfeng Xiao
Purpose.The aim of this study was to investigate the effect of phosphotyrosine interaction domain.containing 1 (PID1) on the insulin-induced activation of the AKT (protein kinase B)/protein.kinase A (PKA)/hormone-sensitive lipase (HSL) pathway and lipolysis..Methods.Sprague–Dawley rats were fed either chow or a high-fat diet (HFD). The levels of insulin,.glycerol, free fatty acids (FFAs) and PID1 mRNA expression were measured in the 2.groups. Furthermore, we examined the role of PID1 in the regulation of the AKT/PKA/HSL.cascade and lipolysis in the 3T3-L1 cell line..Results.Adipose tissue from HFD rats exhibited elevated PID1 expression, which showed a positive.correlation with insulin levels and lipolysis. In 3T3-L1 adipocytes, we found that the antilipolytic.effect of insulin is mediated by AKT and that phosphorylated AKT results in the promotion.of PDE3B expression, the dephosphorylation of PKA and HSL and the suppression of.glycerol release. However, overexpression of PID1 and treatment with 1 μM isoproterenol.and 100 nM insulin for 24 h resulted in an increased release of glycerol and a noticeable inhibition.of AKT phosphorylation, PDE3B expression and the phosphorylation of PKA/HSL in.3T3-L1 cells. In contrast, knockdown of PID1 and treatment with the above reagents inhibited.lipolysis and activated the phosphorylation of AKT, which resulted in the dephosphorylation.of PKA and HSL..Conclusions.Our findings indicate that PID1 in adipose tissue increases lipolysis by altering the antilipolytic.action of insulin. This suggests that PID1 may represent a new therapeutic target to ameliorate.adipocyte lipolysis and hence improve insulin sensitivity.
影响因子:
3.7
作者:
Chunyan Yin;Wei hua Liu;Yuesheng Liu;Li Wang;Yanfeng Xiao
通讯作者:
Yanfeng Xiao